Key Findings:  The current literature suggests there may be a therapeutic use for medical cannabidiol-rich cannabis in the treatment of many of the symptoms of autism spectrum disorders, especially irritability. However, there need to be more long-term and placebo-controlled trials evaluating the safety and efficacy in this population.
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  United States
Year of Pub:  2021
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Unspecified
Chemotype:  Chemotype III